Form 4: Amprius Technologies Executive Jonathan Bornstein Acquires 558,930 Restricted Stock Units

Jonathan Bornstein, President of Amprius Lab, acquired 558,930 restricted stock units in Amprius Technologies, Inc.

Summary

• On March 19, 2024, Jonathan Bornstein, President of Amprius Lab at Amprius Technologies, Inc., acquired 558,930 restricted stock units (RSUs).
• Each RSU represents the right to receive one share of Amprius Technologies' common stock.
• The RSUs vest over time, with 1/16th of the shares vesting on May 20, 2024, and then quarterly on August 20, November 20, February 20, and May 20, until fully vested on February 20, 2028.
• The vesting is contingent upon Bornstein's continued service with the company.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's moderately positive as it incentivizes key personnel.

Positives

• The acquisition of restricted stock units aligns Jonathan Bornstein's interests with the long-term success of Amprius Technologies.
• The vesting schedule incentivizes continued service and commitment from a key executive.

Future Outlook

The vesting schedule suggests a commitment to long-term value creation at Amprius Technologies.

Industry Context

Stock-based compensation is a common practice in the technology industry to attract and retain key talent and align their interests with shareholders.

Comparison to Industry Standards

• Restricted stock units are a standard form of equity compensation used by companies like Tesla, QuantumScape, and Solid Power to incentivize executives.
• The vesting schedule of 1/16th quarterly is fairly typical, aligning with industry norms for retention.

Stakeholder Impact

• Shareholders may view this as a positive sign, indicating that key management is incentivized to improve company performance.
• Employees may see this as a sign of stability and commitment from the company to its leadership.

Key Dates